Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Validate Key Therapeutic Targets and Biomarkers During Allergen Exposure in Subjects With Allergic Rhinitis

NCT00348361 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00348361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00348361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Validate Key Therapeutic Targets and Biomarkers During Allergen Exposure in Subjects With Allergic Rhinitis
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2005
Completion date
Not reported
Enrollment
48
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis